MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
116 M |
Market Cap[1] |
$ 213 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
Neurocrine Biosciences
NBIX
|
$ 135.71 | 0.68 % | $ 13.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 231.83 | 0.11 % | $ 30.4 B | Nasdaq Global Select Market,SPB | USA |
 |
NuCana plc
NCNA
|
$ 0.99 | 0.98 % | $ 11.1 B | Nasdaq Global Select Market |  Britain |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
Burford Capital Limited
BUR
|
$ 3.0 | 0.15 % | $ 657 M | NYSE | Britain |
 |
Aprea Therapeutics
APRE
|
$ 0.58 | 2.27 % | $ 3.79 M | Nasdaq Global Select Market,SPB | USA |
 |
LogicBio Therapeutics
LOGC
|
- | - | $ 229 M | Nasdaq Global Market | USA |
 |
AnaptysBio
ANAB
|
$ 46.61 | 4.37 % | $ 1.35 B | Nasdaq Global Select Market,SPB | USA |
 |
Anika Therapeutics
ANIK
|
$ 19.98 | 2.17 % | $ 286 M | Nasdaq Global Select Market,SPB | USA |
 |
Minerva Neurosciences
NERV
|
$ 2.35 | 2.98 % | $ 19.9 M | Nasdaq Global Market | USA |
 |
Merrimack Pharmaceuticals
MACK
|
- | - | $ 216 M | Nasdaq Global Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 10.34 | 1.35 % | $ 283 M | Nasdaq Global Market,SPB |  Israel |
 |
argenx SE
ARGX
|
$ 819.14 | 3.42 % | $ 50.2 B | Nasdaq Global Select Market |  Niderland |
 |
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | USA |
 |
Bristol-Myers Squibb Company
BMY
|
$ 59.75 | 0.12 % | $ 122 B | NYSE,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.8 | 1.35 % | $ 133 M | Nasdaq Global Select Market | USA |
 |
Cabaletta Bio
CABA
|
$ 1.41 | 0.5 % | $ 142 M | Nasdaq Global Select Market | USA |
 |
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market |  Canada |
 |
CytomX Therapeutics
CTMX
|
$ 2.28 | 8.07 % | $ 314 M | Nasdaq Global Select Market | USA |
 |
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Novavax
NVAX
|
$ 11.26 | 1.42 % | $ 1.82 B | Nasdaq Global Select Market | USA |
 |
Novo Nordisk A/S
NVO
|
$ 38.83 | 0.14 % | $ 173 B | NYSE |  Danmark |
 |
Novartis AG
NVS
|
$ 150.62 | 0.16 % | $ 292 B | NYSE |  Schweiz |
 |
Atara Biotherapeutics
ATRA
|
$ 9.18 | 2.64 % | $ 115 M | Nasdaq Global Select Market,SPB | USA |
 |
Ocular Therapeutix
OCUL
|
$ 6.87 | 2.5 % | $ 1.29 B | Nasdaq Global Select Market | USA |
 |
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 6.58 | 1.03 % | $ 572 M | Nasdaq Global Select Market | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 16.51 | 0.72 % | $ 2.22 B | Nasdaq Global Market | Canada |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | USA |
 |
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | USA |
 |
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.32 | 0.11 % | $ 352 M | Nasdaq Global Select Market | USA |
 |
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | USA |
 |
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market | Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | USA |
 |
Axsome Therapeutics
AXSM
|
$ 157.14 | 0.08 % | $ 7.82 B | Nasdaq Global Market,SPB | USA |
|
Oyster Point Pharma
OYST
|
- | - | $ 300 M | Nasdaq Global Select Market | USA |
 |
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.07 | 0.97 % | $ 169 M | Nasdaq Global Select Market | Israel |
 |
9 Meters Biopharma
NMTR
|
- | -42.97 % | $ 1.05 M | Nasdaq Global Select Market | USA |
 |
Fortress Biotech
FBIO
|
$ 1.87 | 0.53 % | $ 52.2 M | Nasdaq Capital Market | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.15 | 3.2 % | $ 280 M | Nasdaq Global Select Market | USA |
 |
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | USA |
 |
Chinook Therapeutics
KDNY
|
- | - | $ 2.6 B | Nasdaq Global Select Market | USA |
|
Foghorn Therapeutics
FHTX
|
$ 1.85 | 2.16 % | $ 117 M | Nasdaq Global Market | USA |
 |
Galectin Therapeutics
GALT
|
$ 3.62 | 0.27 % | $ 231 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.